Jersey City, New Jersey, USA: Kuehne+Nagel has set up a new network of eight, temperature-controlled warehouses for the US healthcare market.
The sites will store temperature-sensitive medicines and vaccines, medical devices and diagnostic kits.
The cross-docking concept “optimises supply chain efficiencies and reduces CO2 emissions”, says Kuehne+Nagel.
“With this solution, Kuehne+Nagel addresses the growing need of the healthcare market for more sustainable and cost-optimized supply chains, in an industry where precise temperature control and timely delivery are paramount,” says the company.
“The cross-dock concept features the loading and unloading of sea freight temperature-controlled containers in a GxP-compliant warehouse near an ocean port, allowing for the prompt return of empty containers to the port. At the temperature-controlled warehouse, the containers are sorted and prepared for road transport to their final destination. This reduces the use of multiple containers and eliminates or lowers detentions charges due to a fast turnaround of container management. “
“Cross-docking optimizes the time that products spend in transit, streamlines the handling process, and reduces costs and CO2 emissions,” said Jeff Garcia, industry champion healthcare for Kuehne+Nagel.
“We began this concept as a piilot program with a large, global human and animal health customer for their animal health division at one warehouse, resulting in a double-digit savings of costs in the container inbound process and cutting CO2 emissions by nearly half. Based on this success, we are proud to be expanding this offering to the healthcare market across the United States.”
